Preliminary injunctions in pharmaceutical patent cases in Japan

Recently, preliminary injunctions were filed and granted successively in pharmaceutical patent cases against generics in Japan. Below are overviews of five cases.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Genetics

Charpentier CRISPR patent gets good news from Japan

14 December 2023 Novelty and inventive step of patent owned by ERS Genomics and Emmanuelle Charpentier withstand challenge at Japan Patent Office | Invalidity proceedings also rejected by JPO in 2021.

Biotechnology

Japan’s IP office upholds CRISPR patent and allows third

1 June 2021 A CRISPR patent filed by scientist Emmanuelle Charpentier alongside the Regents of the University of California and the University of Vienna has been upheld by the Japan Patent Office.

More features

The Quintara decision: Defining trade secrets in federal cases

To disclose or not: Pharma patents face new AI reality

Trade secrets go global: How brand owners face a high-stakes battlefront

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Trump’s march-in rights threat: Why pharma is rethinking collaborations

GSK escalates mRNA COVID-19 vaccine dispute

Preliminary injunctions in pharmaceutical patent cases in Japan

More on this story

Editor's picks

Editor's picks

More features